Emerging information from different basic and clinical arenas has centered attention on the crucial role of insulin during stress and in particular in the acutely ill patient. Elegant clinical studies indicate that aggressive glucose control reduces mortality, while the role of insulin, independent of glucose control, is also being evaluated. The purpose of this meeting is to review the most currently relevant information assessing insulin therapy in the acutely ill as well as to explore the potential underlying mechanisms involved in these processes.


Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases
American Association of Clinical Endocrinologists
American Diabetes Association
The Endocrine Society
Society of Critical Care Medicine